trial · primary record
Capecitabine
Gastroenteropancreatic Neuroendocrine Tumors
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 123 |
| Primary completion | 2031-10-11 |
| Primary endpoint | 1-Year Progression-Free Survival (PFS) |
| Registry ID | NCT07910760 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:57.539Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07910760
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Capecitabine · approval
- Capecitabine · compound